PYSZCZYMUKA GREG 4
4 · AYTU BIOPHARMA, INC · Filed Apr 2, 2024
Insider Transaction Report
Form 4
PYSZCZYMUKA GREG
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Shares
2024-03-31+208→ 22,768 total - Exercise/Conversion
Restricted Stock Units
2024-03-31−208→ 834 total→ Common Shares (208 underlying)
Footnotes (1)
- [F1]Restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on March 31, 2022, and vest quarterly beginning March 31, 2023 and ending March 31, 2025.